Medical Laboratory Technologist
Based in Cambridge, Good Start Genetics, Inc. conducts genetic diagnostic carrier testing for the reproductive market. Our clinical molecular diagnostics laboratory is CLIA and CAP certified. Good Start Genetics is building a great team with experienced professionals. Please visit www.goodstartgenetics.com for more company information.
Good Start Genetics is seeking a full-time Medical Laboratory Technologist.
We seek a highly motivated individual who can utilize their knowledge of biology and practical clinical experience to perform the Accessioning and DNA extraction functions necessary for our company's genetic screening assays.
- Performs the technical duties of a clinical molecular laboratory technologist. Techniques may include: DNA extraction, Next Generation sequencing, Sanger sequencing, capillary electrophoresis, mutation detection using DNA-based assays.
- Follows run schedules and ensures patient samples are processed within established turn around time.
- Ensures availability of appropriately qualified reagents and supplies for the clinical laboratory.
- Acts proactively to flag exceptions: assay, clinical, and/or administrative.
- Maintains required assay documentation including proper specimen handling, labeling and preparation of worksheets.
- Performs and documents clinical validation experiments for new clinical molecular assays.
- Responsibilities may also include specimen processing.
We are looking for team players who are willing to accept personal accountability for successful job performance and who have a willingness to learn new skills, as well as continually improve existing skill set.
- Must have a B.S. from a U.S. institution or have official documentation of equivalency. Degree must include the following course work: 16 semester hours of chemistry (at least six of these in inorganic chemistry), 16 semester hours of biology courses relevant to medical sciences and at least three semester hours of mathematics.
- Proficiency in MS Office and email, particularly Excel.
- One year or more of experience working in a clinical laboratory performing CLIA high complexity testing, or working with clinical samples and diagnostic assays.
- Familiarity with high through-put platforms, thermal cyclers, capillary electrophoresis instruments, and other common laboratory equipment.
- Ability to work both independently and in a team environment.
- High attention to detail
- Excellent organizational and time-management skills.
- Superior oral and written communication skills.
- Ability to work in a fast-paced environment.
- Competitive salary, commensurate with experience
- Benefits package available includes: Medical, dental, vision insurance, Life and disability insurance, 401(k) plan, bonus plan, paid vacation and holidays
To apply please submit your resume which specifically addresses why you are interested in this position, why you are qualified, specific examples of success in similar positions, your work style, and when you are available to begin workingtocareers@gsgeneticscom
No phone calls please. Resumes form third party vendors will not be accepted.
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- May 22, 2013 Drug Repurposing and Reformulation: At the Crossroads of IP, Clinical and Business Strategies
- May 8, 2013 MassBio Recognizes Marlborough as a Major Massachusetts Life Sciences Hub: City Biz List - 5/6/2013
- May 8, 2013 Marlborough commended as tech hub: MetroWest Daily News - 5/7/2013
- May 6, 2013 MassBio Recognizes Marlborough as a Major Life Sciences Hub in Massachusetts: PR.com - 5/5/2013
- May 6, 2013 Elections may have big impact on tech, biotech: Boston Globe - 5/5/2013